<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7438223\results\search\disease\results.xml">
  <result pre=": bold;} span.year {font-family : courier ; font-style : italic;}" exact="Diabetes" post="Res Clin PractDiabetes Res. Clin. PractDiabetes Research and Clinical"/>
  <result pre="doi: 10.1016/j.diabres.2020.108372108372 : Article Caring for children and adolescents with" exact="type 1" post="diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology"/>
  <result pre=": Article Caring for children and adolescents with type 1" exact="diabetes" post="mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED)"/>
  <result pre="and adolescents with type 1 diabetes mellitus: Italian Society for" exact="Pediatric" post="Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia d'AnnunzioGiuseppeaâ�ŽMaffeisClaudiobCherubiniValentinocRabboneIvanadScaramuzzaAndreaeSchiaffiniRiccardofMinutoNicolaaPiccoloGianlucaaMaghnieMohamadag[a],"/>
  <result pre="d'AnnunzioGiuseppeaâ�ŽMaffeisClaudiobCherubiniValentinocRabboneIvanadScaramuzzaAndreaeSchiaffiniRiccardofMinutoNicolaaPiccoloGianlucaaMaghnieMohamadag[a], [b], [c], [d], [e], [f], [g], â�ŽCorresponding author at:" exact="Pediatric" post="Clinic and Endocrinology, Regional Center for Pediatric Diabetes, IRCCS"/>
  <result pre="â�ŽCorresponding author at: Pediatric Clinic and Endocrinology, Regional Center for" exact="Pediatric" post="Diabetes, IRCCS Istituto Giannina Gaslini, Genoa, Italy, Via Gaslini"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="the impact of COVID-19 pandemia in children and adolescents with" exact="type 1 diabetes mellitus," post="to analyze the clinical characteristics of the infection and"/>
  <result pre="of COVID-19 pandemia in children and adolescents with type 1" exact="diabetes mellitus," post="to analyze the clinical characteristics of the infection and"/>
  <result pre="1 diabetes mellitus, to analyze the clinical characteristics of the" exact="infection" post="and to propose clinical practice recommendations from the Italian"/>
  <result pre="to propose clinical practice recommendations from the Italian Society for" exact="Pediatric" post="Endocrinology and Diabetology (ISPED). Methods A literature search was"/>
  <result pre="out in the guideline databases, Medline and Embase and in" exact="Diabetes" post="Societies websites until May 21st, 2020 for guidelines and"/>
  <result pre="websites until May 21st, 2020 for guidelines and recommendations on" exact="type 1 diabetes mellitus" post="management during COVID-19 pandemic. Results COVID-19 infection in pediatric"/>
  <result pre="May 21st, 2020 for guidelines and recommendations on type 1" exact="diabetes mellitus" post="management during COVID-19 pandemic. Results COVID-19 infection in pediatric"/>
  <result pre="type 1 diabetes mellitus management during COVID-19 pandemic. Results COVID-19" exact="infection" post="in pediatric patients seems to be clinically less severe"/>
  <result pre="years) and better prognosis. Clinical manifestations include mild, moderate, severe" exact="disease" post="up to critical illness. There is currently no evidence"/>
  <result pre="is currently no evidence suggesting a higher risk of COVID-19" exact="infection" post="in children with diabetes than unaffected peers. Besides general"/>
  <result pre="suggesting a higher risk of COVID-19 infection in children with" exact="diabetes" post="than unaffected peers. Besides general recommendations for pediatric patients,"/>
  <result pre="specific measures for patients with diabetes. Conclusion COVID-19 outbreak modified" exact="type 1" post="diabetes management, and telemedicine has been demonstrating to be"/>
  <result pre="for patients with diabetes. Conclusion COVID-19 outbreak modified type 1" exact="diabetes" post="management, and telemedicine has been demonstrating to be an"/>
  <result pre="psychological aspects deserve attention and future researchs are mandatory. Keywords" exact="Type 1" post="diabetes mellitus COVID-19 pandemia Clinical recommendations Infectious disease Pediatric"/>
  <result pre="deserve attention and future researchs are mandatory. Keywords Type 1" exact="diabetes mellitus" post="COVID-19 pandemia Clinical recommendations Infectious disease Pediatric age group"/>
  <result pre="mandatory. Keywords Type 1 diabetes mellitus COVID-19 pandemia Clinical recommendations" exact="Infectious" post="disease Pediatric age group Clinical research 1 Introduction In"/>
  <result pre="Keywords Type 1 diabetes mellitus COVID-19 pandemia Clinical recommendations Infectious" exact="disease" post="Pediatric age group Clinical research 1 Introduction In December"/>
  <result pre="Type 1 diabetes mellitus COVID-19 pandemia Clinical recommendations Infectious disease" exact="Pediatric" post="age group Clinical research 1 Introduction In December 2019"/>
  <result pre="research 1 Introduction In December 2019 a new RNA betacoronavirus" exact="infection" post="emerged in Wuhan, China [1]. It has been recognized"/>
  <result pre="[1]. It has been recognized as causative factor of severe" exact="pneumonia" post="and other systemic complications [1]. At the end of"/>
  <result pre="been recognized as causative factor of severe pneumonia and other" exact="systemic" post="complications [1]. At the end of January 2020, the"/>
  <result pre="the end of January 2020, the WHO named this betacoronavirus" exact="infection" post="COVID-19 and defined it as a global epidemic communicable"/>
  <result pre="it as a global epidemic communicable form of pneumonia. The" exact="disease" post="spread rapidly worldwide and by March 11 the COVID-19"/>
  <result pre="March 11 the COVID-19 outbreak was classified as a pandemic" exact="disease" post="[2]. Compared with other previous coronavirus epidemics [i.e Severe"/>
  <result pre="pandemic disease [2]. Compared with other previous coronavirus epidemics [i.e" exact="Severe" post="Acute Respiratory Syndrome (SARS) in 2003, and Middle East"/>
  <result pre="disease [2]. Compared with other previous coronavirus epidemics [i.e Severe" exact="Acute" post="Respiratory Syndrome (SARS) in 2003, and Middle East Respiratory"/>
  <result pre="[2]. Compared with other previous coronavirus epidemics [i.e Severe Acute" exact="Respiratory" post="Syndrome (SARS) in 2003, and Middle East Respiratory Syndrome"/>
  <result pre="Compared with other previous coronavirus epidemics [i.e Severe Acute Respiratory" exact="Syndrome" post="(SARS) in 2003, and Middle East Respiratory Syndrome (MERS)"/>
  <result pre="Severe Acute Respiratory Syndrome (SARS) in 2003, and Middle East" exact="Respiratory" post="Syndrome (MERS) in 2014], COVID-19 has spread more rapidly,"/>
  <result pre="Acute Respiratory Syndrome (SARS) in 2003, and Middle East Respiratory" exact="Syndrome" post="(MERS) in 2014], COVID-19 has spread more rapidly, probably"/>
  <result pre="The most recognized form of COVID-19 transmission is through large" exact="respiratory" post="droplets. The virus has been also found in tears,"/>
  <result pre="of affected individuals [4]. The clinical features of the COVID-19" exact="infection" post="vary from being asymptomatic to fever, dry cough and"/>
  <result pre="being asymptomatic to fever, dry cough and fatigue up to" exact="acute" post="respiratory distress syndrome with multiorgan involvement and death [5]."/>
  <result pre="asymptomatic to fever, dry cough and fatigue up to acute" exact="respiratory" post="distress syndrome with multiorgan involvement and death [5]. Other"/>
  <result pre="fever, dry cough and fatigue up to acute respiratory distress" exact="syndrome" post="with multiorgan involvement and death [5]. Other symptoms include"/>
  <result pre="in 50s, with a prevalence of male gender [4]. Infected" exact="adult" post="patients who developed acute respiratory distress syndrome were usually"/>
  <result pre="prevalence of male gender [4]. Infected adult patients who developed" exact="acute" post="respiratory distress syndrome were usually affected by other comorbidities"/>
  <result pre="of male gender [4]. Infected adult patients who developed acute" exact="respiratory" post="distress syndrome were usually affected by other comorbidities [5]."/>
  <result pre="gender [4]. Infected adult patients who developed acute respiratory distress" exact="syndrome" post="were usually affected by other comorbidities [5]. The aim"/>
  <result pre="of our study was to analyze available data about COVID-19" exact="infections" post="and type 1 diabetes mellitus, and to formulate recommendations"/>
  <result pre="study was to analyze available data about COVID-19 infections and" exact="type 1 diabetes mellitus," post="and to formulate recommendations for children and adolescents with"/>
  <result pre="to analyze available data about COVID-19 infections and type 1" exact="diabetes mellitus," post="and to formulate recommendations for children and adolescents with"/>
  <result pre="recommendations for children and adolescents with or who may develop" exact="type 1 diabetes mellitus" post="in the time of Covid-19 infection. 2 Methods A"/>
  <result pre="children and adolescents with or who may develop type 1" exact="diabetes mellitus" post="in the time of Covid-19 infection. 2 Methods A"/>
  <result pre="out in the guideline databases, Medline and Embase and in" exact="Diabetes" post="Societies websites until May 21st, 2020 for guidelines and"/>
  <result pre="websites until May 21st, 2020 for guidelines and recommendations on" exact="type 1 diabetes mellitus" post="management during COVID-19 pandemic. The search terms used were:"/>
  <result pre="May 21st, 2020 for guidelines and recommendations on type 1" exact="diabetes mellitus" post="management during COVID-19 pandemic. The search terms used were:"/>
  <result pre="used were: COVID or COVID-19 or coronavirus or SARS-CoV2, and" exact="type 1 diabetes mellitus," post="and children, and adolescents, and recommendations. The searches were"/>
  <result pre="COVID or COVID-19 or coronavirus or SARS-CoV2, and type 1" exact="diabetes mellitus," post="and children, and adolescents, and recommendations. The searches were"/>
  <result pre="mellitus, and children, and adolescents, and recommendations. The searches were" exact="limited" post="to papers published in English. A descriptive analysis was"/>
  <result pre="was performed. 3 Results 3.1 COVID-19 in pediatric patients COVID-19" exact="infection" post="in pediatric patients seems to be clinically less severe"/>
  <result pre="transmission has not been certainly ruled out [10], [11]; a" exact="lower" post="risk has been recently ascribed to an age-dependent expression"/>
  <result pre="1â€&quot;14Â days, up to 24Â days. Children affected by COVID-19" exact="infection" post="are generally asymptomatic increasing the risk of prolonged spreading"/>
  <result pre="In fact, in more than 90% of affected children, the" exact="infection" post="is clinically silent or is characterized by mild to"/>
  <result pre="nausea, vomiting, and diarrhea. Clinical manifestations include mild, moderate, severe" exact="disease" post="up to critical illness, including severe pneumonia, septic shock,"/>
  <result pre="moderate, severe disease up to critical illness, including severe pneumonia," exact="septic shock," post="refractory metabolic acidosis, coagulation dysfunction [13]. No chest abnormalities"/>
  <result pre="up to critical illness, including severe pneumonia, septic shock, refractory" exact="metabolic acidosis," post="coagulation dysfunction [13]. No chest abnormalities have been reported"/>
  <result pre="pneumonia, septic shock, refractory metabolic acidosis, coagulation dysfunction [13]. No" exact="chest" post="abnormalities have been reported in 20% of affected children;"/>
  <result pre="reported in 20% of affected children; in the remaining cases" exact="chest" post="computed tomography imaging have revealed unilateral or bilateral sub"/>
  <result pre="in the remaining cases chest computed tomography imaging have revealed" exact="unilateral" post="or bilateral sub pleural ground glass opacities, and consolidation"/>
  <result pre="remaining cases chest computed tomography imaging have revealed unilateral or" exact="bilateral" post="sub pleural ground glass opacities, and consolidation with surrounding"/>
  <result pre="chest computed tomography imaging have revealed unilateral or bilateral sub" exact="pleural" post="ground glass opacities, and consolidation with surrounding halo sign,"/>
  <result pre="ground glass opacities, and consolidation with surrounding halo sign, without" exact="pleural" post="effusion [14]. COVID-19 pneumonia can be superimposed with other"/>
  <result pre="consolidation with surrounding halo sign, without pleural effusion [14]. COVID-19" exact="pneumonia" post="can be superimposed with other types of pathogens, particularly"/>
  <result pre="transmission. Moreover, the more active innate immune response, the healthier" exact="respiratory" post="tract and the fewer comorbidities as compared to adults,"/>
  <result pre="as well as the different distribution, maturation, and functioning of" exact="viral" post="receptors might partially explain the relative resistance to COVID-19"/>
  <result pre="viral receptors might partially explain the relative resistance to COVID-19" exact="infection" post="[15]. Recently the Coronavirus Infection in Pediatric Emergency Departments"/>
  <result pre="the relative resistance to COVID-19 infection [15]. Recently the Coronavirus" exact="Infection" post="in Pediatric Emergency Departments (CONFIDENCE) study has been published."/>
  <result pre="resistance to COVID-19 infection [15]. Recently the Coronavirus Infection in" exact="Pediatric" post="Emergency Departments (CONFIDENCE) study has been published. It involved"/>
  <result pre="difficulties (23% of children). In this cohort 9 patients received" exact="respiratory" post="support [16]. 3.2 Diabetes mellitus and infectious diseases Previous"/>
  <result pre="In this cohort 9 patients received respiratory support [16]. 3.2" exact="Diabetes mellitus" post="and infectious diseases Previous observations report an increased susceptibility"/>
  <result pre="9 patients received respiratory support [16]. 3.2 Diabetes mellitus and" exact="infectious diseases" post="Previous observations report an increased susceptibility to infections among"/>
  <result pre="Diabetes mellitus and infectious diseases Previous observations report an increased" exact="susceptibility to" post="infections among patients with both type 1 and type"/>
  <result pre="and infectious diseases Previous observations report an increased susceptibility to" exact="infections" post="among patients with both type 1 and type 2"/>
  <result pre="report an increased susceptibility to infections among patients with both" exact="type 1" post="and type 2 diabetes mellitus, responsible of increased morbidity"/>
  <result pre="susceptibility to infections among patients with both type 1 and" exact="type 2" post="diabetes mellitus, responsible of increased morbidity and mortality [17],"/>
  <result pre="infections among patients with both type 1 and type 2" exact="diabetes mellitus," post="responsible of increased morbidity and mortality [17], [18], [19],"/>
  <result pre="Hyperglycemia may increase the virulence of different pathogens by enhancing" exact="bacterial" post="replication and facilitating their attachment to epithelial cells favoring"/>
  <result pre="pathogens by enhancing bacterial replication and facilitating their attachment to" exact="epithelial" post="cells favoring immune system dysfunction [21], [22], [23]. A"/>
  <result pre="study aimed to evaluate humoral factors in pediatric patients with" exact="type 1" post="diabetes showed lower IgG and C3 levels in poorly"/>
  <result pre="to evaluate humoral factors in pediatric patients with type 1" exact="diabetes" post="showed lower IgG and C3 levels in poorly controlled"/>
  <result pre="humoral factors in pediatric patients with type 1 diabetes showed" exact="lower" post="IgG and C3 levels in poorly controlled disease as"/>
  <result pre="diabetes showed lower IgG and C3 levels in poorly controlled" exact="disease" post="as compared to patients with satisfactory degree of metabolic"/>
  <result pre="patients with satisfactory degree of metabolic control [24]. Moreover, several" exact="viral" post="infections have been considered as possible triggers of the"/>
  <result pre="with satisfactory degree of metabolic control [24]. Moreover, several viral" exact="infections" post="have been considered as possible triggers of the autoimmune"/>
  <result pre="viral infections have been considered as possible triggers of the" exact="autoimmune" post="process leading to clinically overt type 1 diabetes mellitus,"/>
  <result pre="possible triggers of the autoimmune process leading to clinically overt" exact="type 1 diabetes mellitus," post="and infectious diseases may accelerate the clinical onset in"/>
  <result pre="of the autoimmune process leading to clinically overt type 1" exact="diabetes mellitus," post="and infectious diseases may accelerate the clinical onset in"/>
  <result pre="process leading to clinically overt type 1 diabetes mellitus, and" exact="infectious diseases" post="may accelerate the clinical onset in at risk subjects"/>
  <result pre="subjects [25], [26], [27], [28]. Several case reports describe severe" exact="infections" post="both in affected children and adults and underline the"/>
  <result pre="affected children and adults and underline the importance of considering" exact="infectious diseases" post="prompt diagnosis, treatment and, when available, prevention as goal"/>
  <result pre="when available, prevention as goal for good management of the" exact="disease" post="[29], [30], [31], [32]. Similarly, diabetic ketoacidosis recovery may"/>
  <result pre="good management of the disease [29], [30], [31], [32]. Similarly," exact="diabetic ketoacidosis" post="recovery may be delayed by concomitant infectious disease [33]."/>
  <result pre="[32]. Similarly, diabetic ketoacidosis recovery may be delayed by concomitant" exact="infectious disease" post="[33]. A US study in 77% type 1 and"/>
  <result pre="Similarly, diabetic ketoacidosis recovery may be delayed by concomitant infectious" exact="disease" post="[33]. A US study in 77% type 1 and"/>
  <result pre="by concomitant infectious disease [33]. A US study in 77%" exact="type 1" post="and 23% type 2 diabetes adolescents reported that respiratory"/>
  <result pre="[33]. A US study in 77% type 1 and 23%" exact="type 2" post="diabetes adolescents reported that respiratory infections were the most"/>
  <result pre="US study in 77% type 1 and 23% type 2" exact="diabetes" post="adolescents reported that respiratory infections were the most common"/>
  <result pre="type 1 and 23% type 2 diabetes adolescents reported that" exact="respiratory" post="infections were the most common kind of infections, responsible"/>
  <result pre="1 and 23% type 2 diabetes adolescents reported that respiratory" exact="infections" post="were the most common kind of infections, responsible for"/>
  <result pre="care, hospitalization, increased economic impact, and health care cost [34]." exact="American" post="Diabetes Association Clinical Practice Recommendations consider vaccinations mandatory for"/>
  <result pre="hospitalization, increased economic impact, and health care cost [34]. American" exact="Diabetes" post="Association Clinical Practice Recommendations consider vaccinations mandatory for patients,"/>
  <result pre="vaccinations mandatory for patients, especially for seasonal influenza and pneumococcal" exact="infection" post="[35]. Despite several evidence suggests the importance of vaccination"/>
  <result pre="several evidence suggests the importance of vaccination in patients with" exact="diabetes mellitus," post="and the lack of association between vaccinations and autoimmunity"/>
  <result pre="association between vaccinations and autoimmunity [36], global coverage is still" exact="lower" post="than expected [37], [38], [39], [40], [41], [42]. As"/>
  <result pre="was not associated with increased risk of islet autoimmunity or" exact="type 1" post="diabetes, and in a group of Italian patients we"/>
  <result pre="not report an increased risk of hospitalization due to H1N1" exact="infection" post="in pediatric patients with type 1 diabetes [43]. 3.3"/>
  <result pre="of hospitalization due to H1N1 infection in pediatric patients with" exact="type 1" post="diabetes [43]. 3.3 Quantifying COVID-19-related risks for patients with"/>
  <result pre="due to H1N1 infection in pediatric patients with type 1" exact="diabetes" post="[43]. 3.3 Quantifying COVID-19-related risks for patients with diabetes"/>
  <result pre="1 diabetes [43]. 3.3 Quantifying COVID-19-related risks for patients with" exact="diabetes mellitus" post="Adult patients with diabetes are included in high risk"/>
  <result pre="[43]. 3.3 Quantifying COVID-19-related risks for patients with diabetes mellitus" exact="Adult" post="patients with diabetes are included in high risk group"/>
  <result pre="COVID-19-related risks for patients with diabetes mellitus Adult patients with" exact="diabetes" post="are included in high risk group for COVID-19 infection"/>
  <result pre="with diabetes are included in high risk group for COVID-19" exact="infection" post="with high mortality and morbidity rate. Diabetes mellitus and"/>
  <result pre="group for COVID-19 infection with high mortality and morbidity rate." exact="Diabetes mellitus" post="and COVID-19 infection might share more links than expected."/>
  <result pre="with high mortality and morbidity rate. Diabetes mellitus and COVID-19" exact="infection" post="might share more links than expected. Both diseases represent"/>
  <result pre="are characterized by multiorgan involvement, even if with peculiar differences:" exact="chronic" post="versus acute condition, communicable versus non communicable, both with"/>
  <result pre="by multiorgan involvement, even if with peculiar differences: chronic versus" exact="acute" post="condition, communicable versus non communicable, both with unknown, at"/>
  <result pre="present, and known long-term complications. Even if common opinion associates" exact="diabetes" post="with higher morbidity and mortality due to infections, it"/>
  <result pre="how it represents a risk factor for prognosis of COVID-19." exact="Diabetes mellitus" post="is indeed one of the most frequent comorbidities observed"/>
  <result pre="disease, as compared with subjects with more mild infection, had" exact="diabetes" post="as a common comorbidity [44]. On the other hand,"/>
  <result pre="comorbidity [44]. On the other hand, since in patients with" exact="diabetes" post="any infectious disease worsens the degree of metabolic control"/>
  <result pre="On the other hand, since in patients with diabetes any" exact="infectious disease" post="worsens the degree of metabolic control with a negative"/>
  <result pre="the other hand, since in patients with diabetes any infectious" exact="disease" post="worsens the degree of metabolic control with a negative"/>
  <result pre="control with a negative effect on the recovery, also COVID-19" exact="infection" post="may generate a vicious circle that would be detrimental"/>
  <result pre="lung involvement [45]. A recent study aimed to establish if" exact="diabetes" post="is a risk factor influencing the outcome and prognosis"/>
  <result pre="factor influencing the outcome and prognosis of COVID-19 reported that" exact="adult" post="patients without other comorbidities were at higher risk of"/>
  <result pre="severe pneumonia, showed higher tissue enzyme levels indicating multiorgan involvement," exact="uncontrolled" post="inflammatory response and hypercoagulable state together with dysregulation of"/>
  <result pre="dysregulation of metabolic control, even if insulin requirement increased after" exact="infection" post="[46]. Worsening of metabolic control affects severity of pneumonia,"/>
  <result pre="severity of pneumonia, together with the coexistence of comorbidities. Therefore," exact="diabetes" post="should be considered as a risk factor for the"/>
  <result pre="Potential mechanisms increasing the risk of COVID-19 among patients with" exact="diabetes" post="are higher affinity cellular binding and efficient virus entry"/>
  <result pre="the cells, decreased virus clearance, reduced T cell function, increased" exact="susceptibility to" post="cytokine storm [47]. Increased expression of ACE2 has been"/>
  <result pre="reduced T cell function, increased susceptibility to cytokine storm [47]." exact="Increased" post="expression of ACE2 has been observed in the lung,"/>
  <result pre="in the lung, kidney, heart, pancreas in animal models of" exact="diabetes" post="[48]. Moreover, higher levels of furin, a cellular protease"/>
  <result pre="protease facilitating virus entry, have been observed in patients with" exact="diabetes mellitus" post="[49]. As for the impact of diabetes among adults"/>
  <result pre="patients with diabetes mellitus [49]. As for the impact of" exact="diabetes" post="among adults COVID-19 infected Italian patients, it has been"/>
  <result pre="patients, it has been reported that the prevalence of pre-existing" exact="diabetes" post="was 8.9%, and the ratio of diabetes in patients"/>
  <result pre="prevalence of pre-existing diabetes was 8.9%, and the ratio of" exact="diabetes" post="in patients who died for COVID-19 infection as compared"/>
  <result pre="the ratio of diabetes in patients who died for COVID-19" exact="infection" post="as compared to general population was 1.75 [50]. The"/>
  <result pre="to general population was 1.75 [50]. The authors concluded that" exact="diabetes" post="does not increase the risk of COVID-19 infection, but"/>
  <result pre="increase mortality rate of 7.3% in patients with pre existing" exact="diabetes" post="as compared to 2.3% mortality rate that has been"/>
  <result pre="rate that has been observed globally [51]. At present, COVID-19" exact="infection" post="in children and adolescents with type 1 diabetes is"/>
  <result pre="[51]. At present, COVID-19 infection in children and adolescents with" exact="type 1" post="diabetes is clinically different as compared to adults, without"/>
  <result pre="present, COVID-19 infection in children and adolescents with type 1" exact="diabetes" post="is clinically different as compared to adults, without increased"/>
  <result pre="to adults, without increased morbidity and mortality. Young patients with" exact="type 1" post="diabetes and COVID-19 infection usually donâ€™t need hospitalization, and"/>
  <result pre="without increased morbidity and mortality. Young patients with type 1" exact="diabetes" post="and COVID-19 infection usually donâ€™t need hospitalization, and careful"/>
  <result pre="and mortality. Young patients with type 1 diabetes and COVID-19" exact="infection" post="usually donâ€™t need hospitalization, and careful management of glycometabolic"/>
  <result pre="receptors in the endocrine pancreas raises the question if COVID-19" exact="infection" post="is a risk factor for development of dysglycemia. A"/>
  <result pre="SARS coronavirus - and not treated with glucocorticoids - showed" exact="transient" post="hyperglycemia due to acute damage of beta cells induced"/>
  <result pre="coronavirus - and not treated with glucocorticoids - showed transient" exact="hyperglycemia" post="due to acute damage of beta cells induced by"/>
  <result pre="not treated with glucocorticoids - showed transient hyperglycemia due to" exact="acute" post="damage of beta cells induced by the virus, occurring"/>
  <result pre="the other hand ACE inhibitors might reduce the severity of" exact="lung inflammation" post="[53]. As for H1N1 viral infection as possible risk"/>
  <result pre="reduce the severity of lung inflammation [53]. As for H1N1" exact="viral infection" post="as possible risk factor for diabetes, it has been"/>
  <result pre="the severity of lung inflammation [53]. As for H1N1 viral" exact="infection" post="as possible risk factor for diabetes, it has been"/>
  <result pre="in vivo, but are not associated with clinical onset of" exact="diabetes mellitus" post="[54]. At present, there is no association between COVID-19"/>
  <result pre="mellitus [54]. At present, there is no association between COVID-19" exact="infection" post="and the increased risk of type 1 diabetes: future"/>
  <result pre="no association between COVID-19 infection and the increased risk of" exact="type 1" post="diabetes: future studies are needed to better define the"/>
  <result pre="better define the role of COVID-19 and autoimmunity. The COVID-19" exact="infection" post="seems to be unusual among patients with type 1"/>
  <result pre="The COVID-19 infection seems to be unusual among patients with" exact="type 1 diabetes mellitus," post="although they are considered a fragile population. It has"/>
  <result pre="infection seems to be unusual among patients with type 1" exact="diabetes mellitus," post="although they are considered a fragile population. It has"/>
  <result pre="the risk of increased frequency of severe ketoacidosis in new-onset" exact="type 1" post="diabetes due to delayed diagnosis - because of fear"/>
  <result pre="of increased frequency of severe ketoacidosis in new-onset type 1" exact="diabetes" post="due to delayed diagnosis - because of fear of"/>
  <result pre="data extracted from studies looking at clinical characteristics of COVID-19" exact="infection" post="and its impact in patients affected by diabetes mellitus."/>
  <result pre="of COVID-19 infection and its impact in patients affected by" exact="diabetes mellitus." post="Table 1 Summary of reviewed papers looking at the"/>
  <result pre="Summary of reviewed papers looking at the impact of COVID-19" exact="infections" post="and diabetes mellitus. Date, Title of paper, Authors Study"/>
  <result pre="reviewed papers looking at the impact of COVID-19 infections and" exact="diabetes mellitus." post="Date, Title of paper, Authors Study type Aim of"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan China: a descriptive study. Lancet 2020;395(10223):507â€&quot;513 [44]"/>
  <result pre="99 patients admitted from 1st to 20th January 2020, including" exact="adult" post="cases of COVID-19 confirmed by RT-PCR. To clarify the"/>
  <result pre="Comorbidity is a worsening predicting factor: 51% had chronicle medical" exact="disease" post="of whom 24% had diabetes mellitus. February 24th, 2020Wu"/>
  <result pre="factor: 51% had chronicle medical disease of whom 24% had" exact="diabetes mellitus." post="February 24th, 2020Wu Z, McGoogan JM. Characteristics of and"/>
  <result pre="McGoogan JM. Characteristics of and important lesson from the Coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: summary of a report"/>
  <result pre="a report of 72,314 cases from the Chinese center for" exact="disease" post="control and prevention. J Am Med Ass 2020 Feb24."/>
  <result pre="Med Ass 2020 Feb24. doi.org/https://doi.org//10.1001/jama.2020.2648 [50] Opinion article, viewpoint.Among a" exact="total" post="of 72.314 cases, the overall case-fatality rate (CFR) was"/>
  <result pre="summarizekey findings from Chinese cases of COVID-19 epidemic. Comorbidities including" exact="diabetes" post="increase the risk of adverse outcome in COVID-19 infection.CFR"/>
  <result pre="A, Singh AK, Misra A. Clinical considerations for patients with" exact="diabetes" post="in times of COVID-19 epidemic. Diabetes Metab Syndr 2020;14:211â€&quot;12"/>
  <result pre="considerations for patients with diabetes in times of COVID-19 epidemic." exact="Diabetes" post="Metab Syndr 2020;14:211â€&quot;12 [65] Clinical considerations. To increase the"/>
  <result pre="patients with diabetes. Diabetic patients have an increased risk of" exact="infection" post="with SARS-CoV-2. Comorbidities and older age worsen the prognosis."/>
  <result pre="Morieri ML, Longato E, Avogaro A. Prevalence and impact of" exact="diabetes" post="among people infected with SARS-CoV-2. JEI 2020; htpps://doi.org/https://doi.org//10.1007/s-40618-020-01236- [49]"/>
  <result pre="a meta-analysis and of local data, showing the prevalence of" exact="diabetes" post="among adults with COVID-19 Diabetes does not increase the"/>
  <result pre="data, showing the prevalence of diabetes among adults with COVID-19" exact="Diabetes" post="does not increase the risk of SARS-CoV-2 infection but"/>
  <result pre="with COVID-19 Diabetes does not increase the risk of SARS-CoV-2" exact="infection" post="but can worsen the outcome of COVID-19. The rate"/>
  <result pre="can worsen the outcome of COVID-19. The rate ratio of" exact="diabetes" post="among patients with adverse disease course was 2.26 in"/>
  <result pre="COVID-19. The rate ratio of diabetes among patients with adverse" exact="disease" post="course was 2.26 in China and 1.75 at the"/>
  <result pre="Dong Y, Zhou H, Zhang Z, Tian C, et al." exact="Diabetes" post="is a risk factor for the progression and prognosis"/>
  <result pre="a risk factor for the progression and prognosis of COVID-19." exact="Diabetes" post="Metab Res Rev 2020;e3319. Research article.Retrospective study on 174"/>
  <result pre="Diabetes Metab Res Rev 2020;e3319. Research article.Retrospective study on 174" exact="adult" post="patients, admitted from 10th to 29th February 2020. To"/>
  <result pre="admitted from 10th to 29th February 2020. To define whether" exact="diabetes" post="influences COVID-19 infection. Diabetes is a risk factor for"/>
  <result pre="29th February 2020. To define whether diabetes influences COVID-19 infection." exact="Diabetes" post="is a risk factor for rapid progression and bad"/>
  <result pre="31st, 2020Muniyappa R, Gubbi S. Perspective: COVID-19 pandemic, coronaviruses, and" exact="diabetes mellitus." post="Am J Physiol Endocrinol Metab 2020 May 1; 318(5):"/>
  <result pre="of COVID-19, its pathophysiology and the potential mechanisms by which" exact="diabetes" post="modulates the host-viral interaction and host immune responses. Importance"/>
  <result pre="2020Garg SK, Rodbard D, Hirsch IB, Forlenza GP. Managing new-onset" exact="type 1" post="diabetes during the COVID-19 pandemic: Challenges and opportunities. Diab"/>
  <result pre="Rodbard D, Hirsch IB, Forlenza GP. Managing new-onset type 1" exact="diabetes" post="during the COVID-19 pandemic: Challenges and opportunities. Diab Technol"/>
  <result pre="[66] Original article To define the role of telemedicine in" exact="type 1" post="diabetes management Telemedicine in an effective approach for the"/>
  <result pre="article To define the role of telemedicine in type 1" exact="diabetes" post="management Telemedicine in an effective approach for the management"/>
  <result pre="Telemedicine in an effective approach for the management of new-onset" exact="type 1" post="diabetes particularly during COVID-19 pandemia 3.4 Adaptation of standard-of-care"/>
  <result pre="an effective approach for the management of new-onset type 1" exact="diabetes" post="particularly during COVID-19 pandemia 3.4 Adaptation of standard-of-care treatment"/>
  <result pre="COVID-19 pandemia 3.4 Adaptation of standard-of-care treatment regimens Several pediatric" exact="diabetes" post="centers have developed and implemented telemedicine services, thus allowing"/>
  <result pre="to share glycemic data and insulin dosage, and to adapt" exact="disease" post="management without close person-to-person contact, thus minimizing the risk"/>
  <result pre="management without close person-to-person contact, thus minimizing the risk of" exact="infection" post="and of metabolic decompensation [57]. Benefit of telemedicine included"/>
  <result pre="to the degree of metabolic control. Telehealth is not only" exact="limited" post="to glycemic control, but needs to be extended to"/>
  <result pre="but needs to be extended to all diabetic team, including" exact="diabetes" post="educators, dieticians, psychologists [59]. Several pediatric teams with a"/>
  <result pre="both patients and families. 4 Patient education and psychological care" exact="Type 1" post="diabetes is a chronic condition requiring complex clinical care"/>
  <result pre="and families. 4 Patient education and psychological care Type 1" exact="diabetes" post="is a chronic condition requiring complex clinical care and"/>
  <result pre="Patient education and psychological care Type 1 diabetes is a" exact="chronic" post="condition requiring complex clinical care and lifelong involvement, and"/>
  <result pre="only on the physical and psychological but also on the" exact="emotional" post="state in children, adolescents, and their caregivers. Intensive insulin"/>
  <result pre="were exposed and the evidence of person-to-person transmission of COVID-19" exact="infection" post="led to the social isolation of patients. Special attention"/>
  <result pre="applied in susceptible populations including children, especially if affected by" exact="chronic" post="conditions like type 1 diabetes, health care providers, and"/>
  <result pre="populations including children, especially if affected by chronic conditions like" exact="type 1" post="diabetes, health care providers, and fragile people. Elevated levels"/>
  <result pre="like type 1 diabetes, health care providers, and fragile people." exact="Elevated" post="levels of stress, anxiety and depression have been reported"/>
  <result pre="health care providers, and fragile people. Elevated levels of stress," exact="anxiety" post="and depression have been reported during the outbreak, together"/>
  <result pre="providers, and fragile people. Elevated levels of stress, anxiety and" exact="depression" post="have been reported during the outbreak, together with the"/>
  <result pre="infected, or infecting parents and relatives [61]. Even if COVID-19" exact="infection" post="in young patients with type 1 diabetes has been"/>
  <result pre="relatives [61]. Even if COVID-19 infection in young patients with" exact="type 1" post="diabetes has been rarely encountered, patients experienced the awareness"/>
  <result pre="Even if COVID-19 infection in young patients with type 1" exact="diabetes" post="has been rarely encountered, patients experienced the awareness of"/>
  <result pre="2 ), ISPED has proposed specific measures for patients with" exact="diabetes" post="(Table 3 ). Table 2 General recommendations. â€¢Stay at"/>
  <result pre="measures for patients with diabetes (Table 3 ). Table 2" exact="General" post="recommendations. â€¢Stay at home, avoid crowded places â€¢Wash your"/>
  <result pre="eyes, nose and mouth â€¢Cover mouth and nose with bent" exact="elbow" post="or tissue when coughing or sneezing â€¢Avoid contacts with"/>
  <result pre="Table 3 ISPED practical recommendations for children and adolescents with" exact="type 1" post="diabetes. â€¢Reassure patients and families that consultations are available"/>
  <result pre="avoiding excessive caloric intake as well as minerals and oligoelements" exact="deficiency" post="by increasing fruit and vegetable intake and reducing high-calorie"/>
  <result pre="including difficult breathing or shortness of breath, persistent pain and" exact="chest" post="pressure, immediately contact general practitioner and the hospital. Intensify"/>
  <result pre="careful sick day management program proposed by International Society for" exact="Pediatric" post="and Adolescents Diabetes (ISPAD) must be followed, together with"/>
  <result pre="management program proposed by International Society for Pediatric and Adolescents" exact="Diabetes" post="(ISPAD) must be followed, together with specific treatment for"/>
  <result pre="(ISPAD) must be followed, together with specific treatment for the" exact="infection" post="[64]. In case of hospitalization, a multidisciplinary management of"/>
  <result pre="pediatric diabetologist and other physicians is mandatory. For adolescents with" exact="type 2" post="diabetes treated with metformin or other antidiabetic drugs, oral"/>
  <result pre="and other physicians is mandatory. For adolescents with type 2" exact="diabetes" post="treated with metformin or other antidiabetic drugs, oral agents"/>
  <result pre="telemedicine is a new safe and effective way for remote" exact="diabetes" post="management [66]. Future research are needed to evaluate the"/>
  <result pre="research are needed to evaluate the impact of COVID-19 in" exact="type 1 diabetes mellitus" post="patients, regarding not only its hypothetical role in disease"/>
  <result pre="needed to evaluate the impact of COVID-19 in type 1" exact="diabetes mellitus" post="patients, regarding not only its hypothetical role in disease"/>
  <result pre="diabetes mellitus patients, regarding not only its hypothetical role in" exact="disease" post="epidemiology, but also the implementation of new management strategies,"/>
  <result pre="short- and long-term impact of telemedicine as current tool for" exact="diabetes" post="care. 6 Organizational strategy for future scenarios At present"/>
  <result pre="the development of new alternative approaches to manage patients with" exact="diabetes" post="is mandatory. The pandemia has removed several burdens to"/>
  <result pre="order to evaluate the consequences of this unpredictable scenario in" exact="diabetes mellitus," post="in particular regarding epidemiology, etiopathogenesis, management, psychological burden, quality"/>
  <result pre="national real-data on the effects of lockdown and 2020Â year" exact="infection" post="rate on the metabolic and psychological outcomes of patients"/>
  <result pre="rate on the metabolic and psychological outcomes of patients with" exact="type 1" post="diabetes 2. Determine the impact of the time of"/>
  <result pre="the metabolic and psychological outcomes of patients with type 1" exact="diabetes" post="2. Determine the impact of the time of infection"/>
  <result pre="1 diabetes 2. Determine the impact of the time of" exact="infection" post="on weight, exercise activity and treatment regimens 3. Develop"/>
  <result pre="to estimate the cumulative incidence of COVID-19 for patients with" exact="type 1" post="diabetes as well as the impact of the infection"/>
  <result pre="the cumulative incidence of COVID-19 for patients with type 1" exact="diabetes" post="as well as the impact of the infection environment"/>
  <result pre="type 1 diabetes as well as the impact of the" exact="infection" post="environment into the development of type 2 diabetes 4."/>
  <result pre="the impact of the infection environment into the development of" exact="type 2" post="diabetes 4. Determine the COVID-19 morbidity in pregnant woman"/>
  <result pre="of the infection environment into the development of type 2" exact="diabetes" post="4. Determine the COVID-19 morbidity in pregnant woman with"/>
  <result pre="woman with long-term effects on glucose metabolism and prevalence of" exact="diabetes mellitus." post="8 Conclusions (Sharing experience) There is currently no evidence"/>
  <result pre="is currently no evidence suggesting a higher risk of COVID-19" exact="infection" post="in children with diabetes than in unaffected peers. In"/>
  <result pre="suggesting a higher risk of COVID-19 infection in children with" exact="diabetes" post="than in unaffected peers. In addition, contrary to adult"/>
  <result pre="with diabetes than in unaffected peers. In addition, contrary to" exact="adult" post="patients with diabetes, there are no reports suggesting that"/>
  <result pre="adult patients with diabetes, there are no reports suggesting that" exact="diabetes" post="is a comorbidity associated with poor outcomes in children"/>
  <result pre="in children and adolescents. Despite the risk that the COVID-19" exact="infection" post="may develop into a more severe form seems to"/>
  <result pre="may develop into a more severe form seems to be" exact="lower" post="if diabetes is well controlled, several practical recommendations may"/>
  <result pre="into a more severe form seems to be lower if" exact="diabetes" post="is well controlled, several practical recommendations may be useful."/>
  <result pre="practical recommendations may be useful. Children and adolescents affected by" exact="type 1" post="diabetes, as for other chronic conditions, need uninterrupted access"/>
  <result pre="and adolescents affected by type 1 diabetes, as for other" exact="chronic" post="conditions, need uninterrupted access to drugs, supplies, technology and"/>
  <result pre="realized the need to develop new and alternative routes for" exact="disease" post="management. The reduction of direct contacts among patients and"/>
  <result pre="with an increased risk of severe decompensation, even if in" exact="absence of" post="COVID-19 infection. In Italy, both adult and pediatric scientific"/>
  <result pre="even if in absence of COVID-19 infection. In Italy, both" exact="adult" post="and pediatric scientific societies have obtained from the Italian"/>
  <result pre="Drugs (Agenzia Italiana del FArmaco, AIFA) that all patients with" exact="type 1" post="and type 2 diabetes can have access to drugs"/>
  <result pre="del FArmaco, AIFA) that all patients with type 1 and" exact="type 2" post="diabetes can have access to drugs and self management"/>
  <result pre="AIFA) that all patients with type 1 and type 2" exact="diabetes" post="can have access to drugs and self management without"/>
  <result pre="Wenjun. Epidemiological characteristics and prevention and control measures of Corona" exact="Virus Disease" post="2019 in children. J Trop Medicine 2020. ISSN 1672-3619,"/>
  <result pre="Epidemiological characteristics and prevention and control measures of Corona Virus" exact="Disease" post="2019 in children. J Trop Medicine 2020. ISSN 1672-3619,"/>
  <result pre="insights on a rapidly changing epidemicJAMA32314202013391340 5WuC.ChenX.CaiY.XiaJ.ZhouX.XuS.Risk Factors associated with" exact="acute" post="respiratory distress syndrome and death in patients with coronavirus"/>
  <result pre="on a rapidly changing epidemicJAMA32314202013391340 5WuC.ChenX.CaiY.XiaJ.ZhouX.XuS.Risk Factors associated with acute" exact="respiratory" post="distress syndrome and death in patients with coronavirus disease"/>
  <result pre="rapidly changing epidemicJAMA32314202013391340 5WuC.ChenX.CaiY.XiaJ.ZhouX.XuS.Risk Factors associated with acute respiratory distress" exact="syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
  <result pre="acute respiratory distress syndrome and death in patients with coronavirus" exact="disease" post="2019 pneumonia in Wuhan, ChinaJAMA Intern Med132020e20099410.1001/jamainternmed.2020.0994 6LeeP.I.HuY.L.ChenP.Y.HuangY.C.HsuehP.R.Are children"/>
  <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, ChinaJAMA Intern Med132020e20099410.1001/jamainternmed.2020.0994 6LeeP.I.HuY.L.ChenP.Y.HuangY.C.HsuehP.R.Are children less susceptible"/>
  <result pre="a better prognosis than adultsActa Paediatr202010.1111/APA.15270 8World Health Organization. Coronavirus" exact="disease" post="2019 (COVID-19): situation report 65; March 2020. https://www.who.int/docs/default-source/coronaviruses/situation-reports/20200325 -sitrep-65-covid-19.pdf."/>
  <result pre="situation report. March 26, 2020. [in Italian] https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_26-marzo202020.pdf. 10WeiM.YuanJ.LiuY.FuT.YuX.ZhangZ.J.Novel coronavirus" exact="infection" post="in hospitalized infants under 1 year of age in"/>
  <result pre="in ChinaJ Am Med Assoc202010.1001/jama.2020.2131 11HongH.WangY.ChungH.T.ChenC.J.Clinical characteristics of novel coronavirus" exact="disease" post="2019 (COVID-19) in newborns, infants and childrenPediatr Neonatol202010.1016/j.pedneo.2020.03.001 12EgloffC.Vauloup-FellousC.PiconeO.MandelbrotL.RoquesP.Evidence"/>
  <result pre="Virol202010.1016/j.jcv.2020.104447 13QiuH.WuJ.HongL.LuoY.SongQ.ChenD.Clinical and epidemiological features of 36 children with coronavirus" exact="disease" post="2019 (COVID-19) in Zhejiang, China: an observational cohort studyLancet"/>
  <result pre="bindingLancet395202056557410.1016/S0140-6736(20)30251-832007145 16Parri N, Lenge M, Buonsenso D for the Coronavirus" exact="Infection" post="in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with"/>
  <result pre="N, Lenge M, Buonsenso D for the Coronavirus Infection in" exact="Pediatric" post="Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in"/>
  <result pre="NEJM 2020, May 1. doi: 10.1056/NEJMc2007617. 17MullerL.M.GorterK.J.HakE.GoudzwaardW.L.SchellevisF.G.HoepelmanA.I.Increased risk of common" exact="infections" post="in patients with type 1 and type 2 diabetes"/>
  <result pre="doi: 10.1056/NEJMc2007617. 17MullerL.M.GorterK.J.HakE.GoudzwaardW.L.SchellevisF.G.HoepelmanA.I.Increased risk of common infections in patients with" exact="type 1" post="and type 2 diabetes mellitusClin Infect Dis413200528128810.1086/43158716007521 18CritchleyJ.A.CareyI.M.HarrisT.DeWildeS.HoskingF.J.CookD.G.Glycemic control"/>
  <result pre="risk of common infections in patients with type 1 and" exact="type 2" post="diabetes mellitusClin Infect Dis413200528128810.1086/43158716007521 18CritchleyJ.A.CareyI.M.HarrisT.DeWildeS.HoskingF.J.CookD.G.Glycemic control and risk of"/>
  <result pre="common infections in patients with type 1 and type 2" exact="diabetes" post="mellitusClin Infect Dis413200528128810.1086/43158716007521 18CritchleyJ.A.CareyI.M.HarrisT.DeWildeS.HoskingF.J.CookD.G.Glycemic control and risk of infections"/>
  <result pre="2 diabetes mellitusClin Infect Dis413200528128810.1086/43158716007521 18CritchleyJ.A.CareyI.M.HarrisT.DeWildeS.HoskingF.J.CookD.G.Glycemic control and risk of" exact="infections" post="among people with type 1 or type 2 diabetes"/>
  <result pre="Dis413200528128810.1086/43158716007521 18CritchleyJ.A.CareyI.M.HarrisT.DeWildeS.HoskingF.J.CookD.G.Glycemic control and risk of infections among people with" exact="type 1" post="or type 2 diabetes in a large primary care"/>
  <result pre="and risk of infections among people with type 1 or" exact="type 2" post="diabetes in a large primary care cohort studyDiabetes Care4120182127213510.2337/dc18-028730104296"/>
  <result pre="of infections among people with type 1 or type 2" exact="diabetes" post="in a large primary care cohort studyDiabetes Care4120182127213510.2337/dc18-028730104296 19MaC.M.YinF.Z.The"/>
  <result pre="with type 1 or type 2 diabetes in a large" exact="primary" post="care cohort studyDiabetes Care4120182127213510.2337/dc18-028730104296 19MaC.M.YinF.Z.The mortality in infectious in"/>
  <result pre="a large primary care cohort studyDiabetes Care4120182127213510.2337/dc18-028730104296 19MaC.M.YinF.Z.The mortality in" exact="infectious" post="in patients with type 2 diabetes compared with non-diabetic"/>
  <result pre="cohort studyDiabetes Care4120182127213510.2337/dc18-028730104296 19MaC.M.YinF.Z.The mortality in infectious in patients with" exact="type 2" post="diabetes compared with non-diabetic population: Infection in type 2"/>
  <result pre="Care4120182127213510.2337/dc18-028730104296 19MaC.M.YinF.Z.The mortality in infectious in patients with type 2" exact="diabetes" post="compared with non-diabetic population: Infection in type 2 diabetesMedicine"/>
  <result pre="in patients with type 2 diabetes compared with non-diabetic population:" exact="Infection" post="in type 2 diabetesMedicine (Baltimore)98242019e1602510.1097/MD.0000000000016025 20ZoppiniG.FedeliU.SchievanoE.DaurizM.TargherG.BonoraE.Mortality from infectious diseases"/>
  <result pre="with type 2 diabetes compared with non-diabetic population: Infection in" exact="type 2" post="diabetesMedicine (Baltimore)98242019e1602510.1097/MD.0000000000016025 20ZoppiniG.FedeliU.SchievanoE.DaurizM.TargherG.BonoraE.Mortality from infectious diseases in diabetesNutr Metab"/>
  <result pre="non-diabetic population: Infection in type 2 diabetesMedicine (Baltimore)98242019e1602510.1097/MD.0000000000016025 20ZoppiniG.FedeliU.SchievanoE.DaurizM.TargherG.BonoraE.Mortality from" exact="infectious diseases" post="in diabetesNutr Metab Cardiovasc Dis28201844445010.1016/j.numecd.2017.12.00729519560 21CasqueiroJ.CasqueiroJ.AlvesC.Infections in patients with"/>
  <result pre="diseases in diabetesNutr Metab Cardiovasc Dis28201844445010.1016/j.numecd.2017.12.00729519560 21CasqueiroJ.CasqueiroJ.AlvesC.Infections in patients with" exact="diabetes" post="mellitus: a review of pathogenesisIndian J Endocrinol Metab16S12012S27S3610.4103/2230-8210.9425322701840 22AkirovA.Diker-CohenT.Masri-IraqiH.Duskin-BitanH.ShimonI.GorshteinA.Outcomes"/>
  <result pre="mellitus: a review of pathogenesisIndian J Endocrinol Metab16S12012S27S3610.4103/2230-8210.9425322701840 22AkirovA.Diker-CohenT.Masri-IraqiH.Duskin-BitanH.ShimonI.GorshteinA.Outcomes of" exact="hyperglycemia" post="in patients with and without diabetes hospitalized for infectious"/>
  <result pre="Endocrinol Metab16S12012S27S3610.4103/2230-8210.9425322701840 22AkirovA.Diker-CohenT.Masri-IraqiH.Duskin-BitanH.ShimonI.GorshteinA.Outcomes of hyperglycemia in patients with and without" exact="diabetes" post="hospitalized for infectious diseasesDiabetes Metab Res Rev3472018e302710.1002/dmrr.3027 23BurekovicA.Dizdarevic-BostandzicA.GodinjakA.Poorly regulated"/>
  <result pre="of hyperglycemia in patients with and without diabetes hospitalized for" exact="infectious" post="diseasesDiabetes Metab Res Rev3472018e302710.1002/dmrr.3027 23BurekovicA.Dizdarevic-BostandzicA.GodinjakA.Poorly regulated blood glucose in"/>
  <result pre="Res Rev3472018e302710.1002/dmrr.3027 23BurekovicA.Dizdarevic-BostandzicA.GodinjakA.Poorly regulated blood glucose in diabetic patients-predictor of" exact="acute" post="infectionsMed Arch68201416316610.5455/medarh.2014.68.163-16625568525 24Del RoioL.R.jrBarbosaS.F.C.das Gracas AlkiminM.Bellinati-PiresR.FloridoM.P.C.IsaacL.Is immunity in diabetic"/>
  <result pre="24Del RoioL.R.jrBarbosaS.F.C.das Gracas AlkiminM.Bellinati-PiresR.FloridoM.P.C.IsaacL.Is immunity in diabetic patients influencing the" exact="susceptibility to" post="infections? Immunoglobulins, complement and phagocytic function in children and"/>
  <result pre="Immunoglobulins, complement and phagocytic function in children and adolescents with" exact="type 1" post="diabetes mellitusPediatr Diabetes6200520621210.1111/j.1399-543X.2005.00136.x16390389 25HyÃ¶tyH.Viruses in type 1 diabetesPediatr Diabetes17Suppl"/>
  <result pre="and phagocytic function in children and adolescents with type 1" exact="diabetes" post="mellitusPediatr Diabetes6200520621210.1111/j.1399-543X.2005.00136.x16390389 25HyÃ¶tyH.Viruses in type 1 diabetesPediatr Diabetes17Suppl 222016566410.1111/pedi.1237027411438"/>
  <result pre="and adolescents with type 1 diabetes mellitusPediatr Diabetes6200520621210.1111/j.1399-543X.2005.00136.x16390389 25HyÃ¶tyH.Viruses in" exact="type 1" post="diabetesPediatr Diabetes17Suppl 222016566410.1111/pedi.1237027411438 26Rodriguez-CalvoT.Enteroviral infections as a trigger for"/>
  <result pre="mellitusPediatr Diabetes6200520621210.1111/j.1399-543X.2005.00136.x16390389 25HyÃ¶tyH.Viruses in type 1 diabetesPediatr Diabetes17Suppl 222016566410.1111/pedi.1237027411438 26Rodriguez-CalvoT.Enteroviral" exact="infections" post="as a trigger for type 1 diabetesCurr Diab Rep1811201810610.1007/s11892-018-1077-230232567"/>
  <result pre="1 diabetesPediatr Diabetes17Suppl 222016566410.1111/pedi.1237027411438 26Rodriguez-CalvoT.Enteroviral infections as a trigger for" exact="type 1" post="diabetesCurr Diab Rep1811201810610.1007/s11892-018-1077-230232567 27TonioloA.CassaniG.PuggioniA.RossiA.ColomboA.OnoderaT.The diabetes pandemic and associated infections:"/>
  <result pre="as a trigger for type 1 diabetesCurr Diab Rep1811201810610.1007/s11892-018-1077-230232567 27TonioloA.CassaniG.PuggioniA.RossiA.ColomboA.OnoderaT.The" exact="diabetes" post="pandemic and associated infections: suggestions for clinical microbiologyRev Med"/>
  <result pre="associated infections: suggestions for clinical microbiologyRev Med Microbiol30201911710.1097/MRM.000000000000015530662163 28RamondettiF.SaccoS.ComelliM.BrunoG.FalorniA.IannilliA.Type 1" exact="diabetes" post="and measles, mumps and rubella childhood infections within the"/>
  <result pre="for clinical microbiologyRev Med Microbiol30201911710.1097/MRM.000000000000015530662163 28RamondettiF.SaccoS.ComelliM.BrunoG.FalorniA.IannilliA.Type 1 diabetes and measles," exact="mumps" post="and rubella childhood infections within the Italian Insulin-dependent Diabetes"/>
  <result pre="microbiologyRev Med Microbiol30201911710.1097/MRM.000000000000015530662163 28RamondettiF.SaccoS.ComelliM.BrunoG.FalorniA.IannilliA.Type 1 diabetes and measles, mumps and" exact="rubella" post="childhood infections within the Italian Insulin-dependent Diabetes RegistryDiabet Med29201276176610.1111/j.1464-5491.2011.03529.x22133003"/>
  <result pre="Med Microbiol30201911710.1097/MRM.000000000000015530662163 28RamondettiF.SaccoS.ComelliM.BrunoG.FalorniA.IannilliA.Type 1 diabetes and measles, mumps and rubella" exact="childhood" post="infections within the Italian Insulin-dependent Diabetes RegistryDiabet Med29201276176610.1111/j.1464-5491.2011.03529.x22133003 29MainesE.FranceschiR.CauvinV.dâ€™AnnunzioG.Pini"/>
  <result pre="Microbiol30201911710.1097/MRM.000000000000015530662163 28RamondettiF.SaccoS.ComelliM.BrunoG.FalorniA.IannilliA.Type 1 diabetes and measles, mumps and rubella childhood" exact="infections" post="within the Italian Insulin-dependent Diabetes RegistryDiabet Med29201276176610.1111/j.1464-5491.2011.03529.x22133003 29MainesE.FranceschiR.CauvinV.dâ€™AnnunzioG.Pini PratoA.CastagnolaE.Iliopsoas"/>
  <result pre="measles, mumps and rubella childhood infections within the Italian Insulin-dependent" exact="Diabetes" post="RegistryDiabet Med29201276176610.1111/j.1464-5491.2011.03529.x22133003 29MainesE.FranceschiR.CauvinV.dâ€™AnnunzioG.Pini PratoA.CastagnolaE.Iliopsoas abscess in adolescents with type"/>
  <result pre="Insulin-dependent Diabetes RegistryDiabet Med29201276176610.1111/j.1464-5491.2011.03529.x22133003 29MainesE.FranceschiR.CauvinV.dâ€™AnnunzioG.Pini PratoA.CastagnolaE.Iliopsoas abscess in adolescents with" exact="type 1" post="diabetes mellitusClin Case Rep3201563864210.1002/ccr3.26726273460 30BazmamounH.RafeeyM.NikipuoriM.GhergherehchiR.Helicobacer pylori infection in children"/>
  <result pre="RegistryDiabet Med29201276176610.1111/j.1464-5491.2011.03529.x22133003 29MainesE.FranceschiR.CauvinV.dâ€™AnnunzioG.Pini PratoA.CastagnolaE.Iliopsoas abscess in adolescents with type 1" exact="diabetes" post="mellitusClin Case Rep3201563864210.1002/ccr3.26726273460 30BazmamounH.RafeeyM.NikipuoriM.GhergherehchiR.Helicobacer pylori infection in children with"/>
  <result pre="adolescents with type 1 diabetes mellitusClin Case Rep3201563864210.1002/ccr3.26726273460 30BazmamounH.RafeeyM.NikipuoriM.GhergherehchiR.Helicobacer pylori" exact="infection" post="in children with type 1 diabetes: a case control"/>
  <result pre="diabetes mellitusClin Case Rep3201563864210.1002/ccr3.26726273460 30BazmamounH.RafeeyM.NikipuoriM.GhergherehchiR.Helicobacer pylori infection in children with" exact="type 1" post="diabetes: a case control studyJHRS1620166871 31ZubairK.U.ShahA.H.FawwadA.SabirR.ButtA.Frequency of urinary tract"/>
  <result pre="with type 1 diabetes: a case control studyJHRS1620166871 31ZubairK.U.ShahA.H.FawwadA.SabirR.ButtA.Frequency of" exact="urinary tract infection" post="and antibiotic sensitivity of uropathogens in patients with diabetesPak"/>
  <result pre="1 diabetes: a case control studyJHRS1620166871 31ZubairK.U.ShahA.H.FawwadA.SabirR.ButtA.Frequency of urinary tract" exact="infection" post="and antibiotic sensitivity of uropathogens in patients with diabetesPak"/>
  <result pre="with diabetesPak J Med Sci3520191664166810.12669/pjms.35.6.11531777512 32LachmandasE.ThiemK.van den HeuvelC.HijmansA.de GalanB.E.TackC.J.Patients with" exact="type 1 diabetes mellitus" post="have impaired IL-1Î² production in response to Mycobacterium tuberculosisEur"/>
  <result pre="J Med Sci3520191664166810.12669/pjms.35.6.11531777512 32LachmandasE.ThiemK.van den HeuvelC.HijmansA.de GalanB.E.TackC.J.Patients with type 1" exact="diabetes mellitus" post="have impaired IL-1Î² production in response to Mycobacterium tuberculosisEur"/>
  <result pre="J Clin Microbiol Infect Dis37201837138010.1007/s10096-017-3145-y29189980 33PawÅ‚owiczM.BirkholzD.NiedzwieckiM.BalcerskaA.Difficulties or mistakes in diagnosing" exact="type 1" post="diabetes in children?â€&quot;demographic factors influencing delayed diagnosisPediatr Diabetes10200954254910.1111/j.1399-5448.2009.00516.x19496971 34KorbelL.EasterlingR.S.PunjaN.SpencerJ.D.The"/>
  <result pre="Microbiol Infect Dis37201837138010.1007/s10096-017-3145-y29189980 33PawÅ‚owiczM.BirkholzD.NiedzwieckiM.BalcerskaA.Difficulties or mistakes in diagnosing type 1" exact="diabetes" post="in children?â€&quot;demographic factors influencing delayed diagnosisPediatr Diabetes10200954254910.1111/j.1399-5448.2009.00516.x19496971 34KorbelL.EasterlingR.S.PunjaN.SpencerJ.D.The burden"/>
  <result pre="children?â€&quot;demographic factors influencing delayed diagnosisPediatr Diabetes10200954254910.1111/j.1399-5448.2009.00516.x19496971 34KorbelL.EasterlingR.S.PunjaN.SpencerJ.D.The burden of common" exact="infections" post="in children and adolescents with diabetes mellitus: a Pediatric"/>
  <result pre="34KorbelL.EasterlingR.S.PunjaN.SpencerJ.D.The burden of common infections in children and adolescents with" exact="diabetes" post="mellitus: a Pediatric Health Information System studyPediatr Diabetes19201851251910.1111/pedi.1259429094435 35American"/>
  <result pre="common infections in children and adolescents with diabetes mellitus: a" exact="Pediatric" post="Health Information System studyPediatr Diabetes19201851251910.1111/pedi.1259429094435 35American Diabetes AssociationStandards of"/>
  <result pre="diabetes mellitus: a Pediatric Health Information System studyPediatr Diabetes19201851251910.1111/pedi.1259429094435 35American" exact="Diabetes" post="AssociationStandards of medical care in diabetesâ€&quot;2012Diabetes Care35Suppl 12012S11S6322187469 36MorganE.HallidayS.R.CampbellG.R.CardwellC.R.PattersonC.C.Vaccinations"/>
  <result pre="AssociationStandards of medical care in diabetesâ€&quot;2012Diabetes Care35Suppl 12012S11S6322187469 36MorganE.HallidayS.R.CampbellG.R.CardwellC.R.PattersonC.C.Vaccinations and" exact="childhood" post="type 1 diabetes mellitus: a meta-analysis of observational studiesDiabetologia59201623724310.1007/s00125-015-3800-826564178"/>
  <result pre="of medical care in diabetesâ€&quot;2012Diabetes Care35Suppl 12012S11S6322187469 36MorganE.HallidayS.R.CampbellG.R.CardwellC.R.PattersonC.C.Vaccinations and childhood" exact="type 1" post="diabetes mellitus: a meta-analysis of observational studiesDiabetologia59201623724310.1007/s00125-015-3800-826564178 37VergerP.BocquierA.VergÃ©lysC.WardJ.Peretti-WatelP.Flu vaccination"/>
  <result pre="care in diabetesâ€&quot;2012Diabetes Care35Suppl 12012S11S6322187469 36MorganE.HallidayS.R.CampbellG.R.CardwellC.R.PattersonC.C.Vaccinations and childhood type 1" exact="diabetes" post="mellitus: a meta-analysis of observational studiesDiabetologia59201623724310.1007/s00125-015-3800-826564178 37VergerP.BocquierA.VergÃ©lysC.WardJ.Peretti-WatelP.Flu vaccination among"/>
  <result pre="surveyBMC Public Health18201856910.1186/s12889-018-5441-629716565 38ArreliasC.C.Bellissimo-RodriguesF.LimaL.C.SilvaA.S.LimaN.K.ZanettiM.L.Hepatitis B vaccination coverage in patients with" exact="diabetes" post="mellitusRev Esc Enferm USP50201625526210.1590/S0080-62342016000020001127384205 39EisenhutM.ChesoverA.MisquithR.NathwaniN.WaltersA.Antibody responses to immunizations in"/>
  <result pre="Esc Enferm USP50201625526210.1590/S0080-62342016000020001127384205 39EisenhutM.ChesoverA.MisquithR.NathwaniN.WaltersA.Antibody responses to immunizations in children with" exact="type 1" post="diabetes mellitus: a case-control studyClin Vaccine Immunol23201687387710.1128/CVI.00400-1627581437 40WolkersP.C.B.YakuwaM.S.PancieriL.Mendes-RodriguesC.FurtadoM.C.C.MelloD.F.Children with"/>
  <result pre="USP50201625526210.1590/S0080-62342016000020001127384205 39EisenhutM.ChesoverA.MisquithR.NathwaniN.WaltersA.Antibody responses to immunizations in children with type 1" exact="diabetes" post="mellitus: a case-control studyClin Vaccine Immunol23201687387710.1128/CVI.00400-1627581437 40WolkersP.C.B.YakuwaM.S.PancieriL.Mendes-RodriguesC.FurtadoM.C.C.MelloD.F.Children with type"/>
  <result pre="1 diabetes mellitus: a case-control studyClin Vaccine Immunol23201687387710.1128/CVI.00400-1627581437 40WolkersP.C.B.YakuwaM.S.PancieriL.Mendes-RodriguesC.FurtadoM.C.C.MelloD.F.Children with" exact="type 1" post="diabetes mellitus: access to special immunobiological and child careRev"/>
  <result pre="mellitus: a case-control studyClin Vaccine Immunol23201687387710.1128/CVI.00400-1627581437 40WolkersP.C.B.YakuwaM.S.PancieriL.Mendes-RodriguesC.FurtadoM.C.C.MelloD.F.Children with type 1" exact="diabetes" post="mellitus: access to special immunobiological and child careRev Esc"/>
  <result pre="is not associated with increased risk of islet autoimmunity or" exact="type 1" post="diabetes in the TEDDY study children. Version 2Diabetologia61201819320210.1007/s00125-017-4448-328990147 42PrincipiN.IughettiL.CappaM.MaffeisC.ChiarelliF.BonaG.Italian"/>
  <result pre="associated with increased risk of islet autoimmunity or type 1" exact="diabetes" post="in the TEDDY study children. Version 2Diabetologia61201819320210.1007/s00125-017-4448-328990147 42PrincipiN.IughettiL.CappaM.MaffeisC.ChiarelliF.BonaG.Italian Pneumococcal"/>
  <result pre="1 diabetes in the TEDDY study children. Version 2Diabetologia61201819320210.1007/s00125-017-4448-328990147 42PrincipiN.IughettiL.CappaM.MaffeisC.ChiarelliF.BonaG.Italian" exact="Pneumococcal" post="Study Group on Diabetes. Streptococcus pneumoniae oropharyngeal colonization in"/>
  <result pre="Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with" exact="type 1" post="diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccineHum"/>
  <result pre="oropharyngeal colonization in school-age children and adolescents with type 1" exact="diabetes" post="mellitus: Impact of the heptavalent pneumococcal conjugate vaccineHum Vaccin"/>
  <result pre="vaccineHum Vaccin Immunother12201629330010.1080/21645515.2015.107266626575615 43RabboneI.ScaramuzzaA.E.IafuscoD.BonfantiR.LombardoF.CherubiniV.Pandemic influenza vaccination coverage in children with" exact="type 1" post="diabetes: analysis from seven Italian centersHum Vaccin71220111291129210.4161/hv.7.12.1833522108031 44ShenoyA.IsmailyM.BajajM.Diabetes and"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan China: a descriptive studyLancet39510223202050751310.1016/S0140-6736(20)30211-732007143 46GuoW.LiM.DongY.ZhouH.ZhangZ.TianC.Diabetes is a"/>
  <result pre="of COVID-19Diabetes Metab Res Rev2020e331910.1002/dmnr.331932233013 47MuniyappaR.GubbiS.Perspective COVID-19 pandemic, coronaviruses, and" exact="diabetes" post="mellitusAm J Physiol Endocrinol Metab31852020E736E74110.1152/ajpendo.00124.202032228322 48WysockiJ.YeM.SolerM.J.GurleyS.B.XiaoH.D.BernsteinK.E.ACE and ACE2 activity"/>
  <result pre="49FernandezC.RysaJ.AlmgrenP.NilssonJ.EngstromG.Orho-MelanderM.Plasma levels of the proprotein convertase furin and incidence of" exact="diabetes" post="and mortalityJ Intern Med284201837738710.1111/joim.1278329888466 50FadiniG.P.MorieriM.L.LongatoE.AvogaroA.Prevalence and impact of diabetes"/>
  <result pre="of diabetes and mortalityJ Intern Med284201837738710.1111/joim.1278329888466 50FadiniG.P.MorieriM.L.LongatoE.AvogaroA.Prevalence and impact of" exact="diabetes" post="among people infected with SARS-CoV-2JEI202010.1007/s-40618-020-01236-2 51WuZ.McGooganJ.M.Characteristics of and important"/>
  <result pre="with SARS-CoV-2JEI202010.1007/s-40618-020-01236-2 51WuZ.McGooganJ.M.Characteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: summary of a report"/>
  <result pre="a report of 72314 cases from the Chinese center for" exact="disease" post="control and preventionJ Am Med Ass202010.1001/jama.2020.2648 52YangJ.K.LinS.S.JiX.J.GuoL.M.Binding of SARS"/>
  <result pre="of SARS coronavirus to its receptor damages islets and causes" exact="acute" post="diabetesActa Diabetol47201019319910.1007/s00592-009-0109-419333547 53BavishiC.MaddoxT.M.MesserliF.H.Coronavirus disease (COVID-19) infection and renin angiotensin"/>
  <result pre="its receptor damages islets and causes acute diabetesActa Diabetol47201019319910.1007/s00592-009-0109-419333547 53BavishiC.MaddoxT.M.MesserliF.H.Coronavirus" exact="disease" post="(COVID-19) infection and renin angiotensin system blockersJAMA Cardiol202010.1001/jamacardio.2020.1282 54CapuaI.MercalliA.Romero-TejedaA.PizzutoM.S.KasloffS.SordiV.Study"/>
  <result pre="damages islets and causes acute diabetesActa Diabetol47201019319910.1007/s00592-009-0109-419333547 53BavishiC.MaddoxT.M.MesserliF.H.Coronavirus disease (COVID-19)" exact="infection" post="and renin angiotensin system blockersJAMA Cardiol202010.1001/jamacardio.2020.1282 54CapuaI.MercalliA.Romero-TejedaA.PizzutoM.S.KasloffS.SordiV.Study of 2009"/>
  <result pre="possible causative agent of diabetesJ Clin Endocrinol Metab10320184343435610.1210/jc.2018-0086230203067 55TattiP.TonoloG.ZanfardinoA.IafuscoD.The CoV-19" exact="infection" post="appears to be unusual among patients with type 1"/>
  <result pre="55TattiP.TonoloG.ZanfardinoA.IafuscoD.The CoV-19 infection appears to be unusual among patients with" exact="type 1 diabetes mellitus," post="although they are considered a fragile population. We think"/>
  <result pre="infection appears to be unusual among patients with type 1" exact="diabetes mellitus," post="although they are considered a fragile population. We think"/>
  <result pre="consequences of COVID-19: Remember general pediatricsJ Pediatrics223202019719810.1016/j.jpeds.2020.05.004 57NÃ¸rgaardC.Telemedicine consultations and" exact="diabetes" post="technology during COVID-19J Diabetes Sci and Technol202010.1177/1932296820929378 58PetersA.L.GargS.The silver"/>
  <result pre="general pediatricsJ Pediatrics223202019719810.1016/j.jpeds.2020.05.004 57NÃ¸rgaardC.Telemedicine consultations and diabetes technology during COVID-19J" exact="Diabetes" post="Sci and Technol202010.1177/1932296820929378 58PetersA.L.GargS.The silver lining to COVID-19: Avoiding"/>
  <result pre="Diabetes Sci and Technol202010.1177/1932296820929378 58PetersA.L.GargS.The silver lining to COVID-19: Avoiding" exact="diabetic ketoacidosis" post="admissions with telehealthDiab Technol Ther.226202010.1089/dia.2020.0187 59JonesM.S.GoleyA.L.1AlexanderB.E.KellerB.E.CaldwellM.M.BuseJ.B.Inpatient transition to virtual"/>
  <result pre="virtual care during covid-19 pandemicDiab Technol Therap226202010.1089/dia.2020.0206 60TorneseG.CeconiV.MonastaL.CarlettiC.FaleschiniE.BarbiE.Glycemic control in" exact="type 1 diabetes mellitus" post="during covid-19 quarantine and the role of in-home physical"/>
  <result pre="during covid-19 pandemicDiab Technol Therap226202010.1089/dia.2020.0206 60TorneseG.CeconiV.MonastaL.CarlettiC.FaleschiniE.BarbiE.Glycemic control in type 1" exact="diabetes mellitus" post="during covid-19 quarantine and the role of in-home physical"/>
  <result pre="associated factors during the initial stage of the 2019 coronavirus" exact="disease" post="(COVID-19) epidemic among the general population in ChinaInt J"/>
  <result pre="another?Prog Cardiovasc DisS0033â€&quot;0620202020300773008310.1016/j.pcad.2020.04.005 63LukÃ¡csA.MayerK.SasvÃ¡riP.BarkaiL.Health-related Quality of Life of adolescents with" exact="type 1" post="diabetes in the context of resiliencePediatr Diab19820181481148610.1111/pedi.12769 64LaffelL.M.LimbertC.PhelanH.VirmaniA.WoodJ.HoferS.E.ISPAD clinical"/>
  <result pre="DisS0033â€&quot;0620202020300773008310.1016/j.pcad.2020.04.005 63LukÃ¡csA.MayerK.SasvÃ¡riP.BarkaiL.Health-related Quality of Life of adolescents with type 1" exact="diabetes" post="in the context of resiliencePediatr Diab19820181481148610.1111/pedi.12769 64LaffelL.M.LimbertC.PhelanH.VirmaniA.WoodJ.HoferS.E.ISPAD clinical practice"/>
  <result pre="adolescents with diabetesPediatr Diabetes19Suppl 27201819320410.1111/pedi.1274130079506 65GuptaR.GhoshA.SinghA.K.MisraA.Clinical considerations for patients with" exact="diabetes" post="in times of COVID-19 epidemicDiabetes Metab Syndr14202021121210.1016/j.dsx.2020.03.00232172175 66GargS.K.RodbardD.HirschI.B.ForlenzaG.P.Managing new-onset"/>
  <result pre="diabetes in times of COVID-19 epidemicDiabetes Metab Syndr14202021121210.1016/j.dsx.2020.03.00232172175 66GargS.K.RodbardD.HirschI.B.ForlenzaG.P.Managing new-onset" exact="type 1" post="diabetes during the COVID-19 pandemic: challenges and opportunitiesDiab Technol"/>
  <result pre="times of COVID-19 epidemicDiabetes Metab Syndr14202021121210.1016/j.dsx.2020.03.00232172175 66GargS.K.RodbardD.HirschI.B.ForlenzaG.P.Managing new-onset type 1" exact="diabetes" post="during the COVID-19 pandemic: challenges and opportunitiesDiab Technol Therap226202010.1089/dia.2020.0161"/>
 </snippets>
</snippetsTree>
